568 results on '"Abdool Karim, Quarraisha"'
Search Results
52. The Preventive Misconception: Experiences from CAPRISA 004
53. Build on HIV investments for future pandemic preparedness
54. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
55. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis
56. Exploring discrepant knowledge of partner sexual behaviour to inform self-risk assessment in a high HIV burdened district in rural KwaZulu-Natal
57. Enhancing HIV Prevention with Injectable Preexposure Prophylaxis
58. The HIV Epidemic in Southern Africa – Is an AIDS-Free Generation Possible?
59. Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events: Results of the CAPRISA Wisebag Study
60. Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial
61. Disclosure of Microbicide Gel Use to Sexual Partners: Influence on Adherence in the CAPRISA 004 Trial
62. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection
63. Exploring discrepant knowledge of partner sexual behaviour to inform self-risk assessment in a high HIV burdened district in rural KwaZulu-Natal.
64. Private support of public health
65. Tenofovir Gel to Prevent HSV-2 Infection
66. Challenges with participant reimbursement: experiences from a post-trial access study
67. Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection
68. HIV Incidence in Young Girls in KwaZulu-Natal, South Africa-Public Health Imperative for Their Inclusion in HIV Biomedical Intervention Trials
69. Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
70. Anti-retrovirals for treatment and prevention – time for new paradigms in our response to the HIV/AIDS epidemic?
71. The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract
72. Global Epidemiology of HIV-AIDS
73. HIV recency testing: should results be disclosed to individuals tested?
74. Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial
75. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
76. Contributors
77. Interventions with youth in high-prevalence areas
78. Integration of Antiretroviral Therapy with Tuberculosis Treatment
79. COVID-19 affects HIV and tuberculosis care
80. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
81. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
82. Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women
83. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa
84. Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial
85. Mechanisms of sexually transmitted infection‐induced inflammation in women: implications forHIVrisk
86. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
87. Recognising individual contributions to collaborative research: limitations of proportional publication counts and proposals for alternatives
88. Practice brief: Adolescents and HIV clinical trials: Ethics, culture, and context
89. The evolving HIV epidemic in South Africa
90. ARV‐based HIV prevention for women – where we are in 2014
91. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
92. HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
93. Development of a prognostic tool exploring female adolescent risk for HIV prevention and PrEP in rural South Africa, a generalised epidemic setting
94. Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa
95. HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
96. Informed Consent for HIV Testing in a South African Hospital: Is It Truly Informed and Truly Voluntary?
97. The Global HIV Epidemic: Current Status and Challenges
98. Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa
99. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study
100. Development of a prognostic tool exploring female adolescent risk for HIV prevention and PrEP in rural South Africa, a generalised epidemic setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.